ID | Description | GeneRatio | BgRatio | p.adjust | Gene ID |
---|---|---|---|---|---|
hsa04140 | Autophagy - animal | 6/14 | 141/8149 | 1.05E-05 | 2475/3091/10,533/9776/5599/5595 |
hsa04930 | Type II diabetes mellitus | 3/14 | 46/8149 | 1.58E-03 | 2475/5599/5595 |
hsa04012 | ErbB signaling pathway | 3/14 | 85/8149 | 4.40E-03 | 2475/5599/5595 |
hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 3/14 | 89/8149 | 4.54E-03 | 2475/3091/5595 |
hsa04657 | IL-17 signaling pathway | 3/14 | 94/8149 | 5.00E-03 | 5599/7128/5595 |
hsa04066 | HIF-1 signaling pathway | 3/14 | 109/8149 | 6.85E-03 | 2475/3091/5595 |
hsa04668 | TNF signaling pathway | 3/14 | 112/8149 | 7.02E-03 | 5599/7128/5595 |
hsa04071 | Sphingolipid signaling pathway | 3/14 | 119/8149 | 7.58E-03 | 5599/4363/5595 |
hsa04068 | FoxO signaling pathway | 3/14 | 131/8149 | 9.14E-03 | 5599/472/5595 |
hsa04210 | Apoptosis | 3/14 | 136/8149 | 9.57E-03 | 5599/472/5595 |
hsa04910 | Insulin signaling pathway | 3/14 | 137/8149 | 9.57E-03 | 2475/5599/5595 |
hsa04150 | mTOR signaling pathway | 3/14 | 156/8149 | 1.24E-02 | 2475/23,175/5595 |
hsa04218 | Cellular senescence | 3/14 | 156/8149 | 1.24E-02 | 2475/472/5595 |
hsa05010 | Alzheimer disease | 4/14 | 384/8149 | 1.85E-02 | 2475/9776/5599/5595 |
hsa04621 | NOD-like receptor signaling pathway | 3/14 | 184/8149 | 1.85E-02 | 5599/7128/5595 |
hsa04613 | Neutrophil extracellular trap formation | 3/14 | 190/8149 | 1.96E-02 | 2475/10,533/5595 |
hsa05169 | Epstein-Barr virus infection | 3/14 | 202/8149 | 2.26E-02 | 960/5599/7128 |
hsa05208 | Chemical carcinogenesis - reactive oxygen species | 3/14 | 223/8149 | 2.57E-02 | 3091/5599/5595 |
hsa04920 | Adipocytokine signaling pathway | 2/14 | 69/8149 | 2.57E-02 | 2475/5599 |
hsa04137 | Mitophagy - animal | 2/14 | 72/8149 | 2.59E-02 | 3091/5599 |
hsa05022 | Pathways of neurodegeneration - multiple diseases | 4/14 | 476/8149 | 2.62E-02 | 2475/9776/5599/5595 |
hsa04658 | Th1 and Th2 cell differentiation | 2/14 | 92/8149 | 3.55E-02 | 5599/5595 |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2/14 | 100/8149 | 3.78E-02 | 5599/5595 |
hsa04064 | NF-kappa B signaling pathway | 2/14 | 104/8149 | 3.78E-02 | 7128/472 |
hsa04620 | Toll-like receptor signaling pathway | 2/14 | 104/8149 | 3.78E-02 | 5599/5595 |
hsa04660 | T cell receptor signaling pathway | 2/14 | 104/8149 | 3.78E-02 | 5599/5595 |
hsa05016 | Huntington disease | 3/14 | 306/8149 | 3.92E-02 | 2475/9776/5599 |
hsa04931 | Insulin resistance | 2/14 | 108/8149 | 3.92E-02 | 2475/5599 |
hsa04722 | Neurotrophin signaling pathway | 2/14 | 119/8149 | 4.53E-02 | 5599/5595 |